title: New reduced volume preparation regimen in colon capsule endoscopy.
abstract: OBJECTIVE
  To evaluate the effectiveness of our proposed bowel preparation method for colon capsule endoscopy.
  
  
  METHODS
  A pilot, multicenter, randomized controlled trial compared our proposed "reduced volume method" (group A) with the "conventional volume method" (group B) preparation regimens. Group A did not drink polyethylene glycol electrolyte lavage solution (PEG-ELS) the day before the capsule procedure, while group B drank 2 L. During the procedure day, groups A and B drank 2 L and 1 L of PEG-ELS, respectively, and swallowed the colon capsule (PillCam COLON® capsule). Two hours later the first booster of 100 g magnesium citrate mixed with 900 mL water was administered to both groups, and the second booster was administered six hours post capsule ingestion as long as the capsule had not been excreted by that time. Capsule videos were reviewed for grading of cleansing level.
  
  
  RESULTS
  Sixty-four subjects were enrolled, with results from 60 analyzed. Groups A and B included 31 and 29 subjects, respectively. Twenty-nine (94%) subjects in group A and 25 (86%) subjects in group B had adequate bowel preparation (ns). Twenty-two (71%) of the 31 subjects in group A excreted the capsule within its battery life compared to 16 (55%) of the 29 subjects in group B (ns). Of the remaining 22 subjects whose capsules were not excreted within the battery life, all of the capsules reached the left side colon before they stopped functioning. A single adverse event was reported in one subject who had mild symptoms of nausea and vomiting one hour after starting to drink PEG-ELS, due to ingesting the PEG-ELS faster than recommended.
  
  
  CONCLUSIONS
  Our proposed reduced volume bowel preparation method for colon capsule without PEG-ELS during the days before the procedure was as effective as the conventional volume method.
authors.affiliation: Division of Screening Technology and Development, Research Center for Cancer Prevention and Screening, National Cancer Center, Tokyo 104-0045, Japan.
authors.forename: Yasuo
authors.initials: Y
authors.lastname: Kakugawa
authors.forename: Yutaka
authors.initials: Y
authors.lastname: Saito
authors.forename: Shoichi
authors.initials: S
authors.lastname: Saito
authors.forename: Kenji
authors.initials: K
authors.lastname: Watanabe
authors.forename: Naoki
authors.initials: N
authors.lastname: Ohmiya
authors.forename: Mitsuyuki
authors.initials: M
authors.lastname: Murano
authors.forename: Shiro
authors.initials: S
authors.lastname: Oka
authors.forename: Tetsuo
authors.initials: T
authors.lastname: Arakawa
authors.forename: Hidemi
authors.initials: H
authors.lastname: Goto
authors.forename: Kazuhide
authors.initials: K
authors.lastname: Higuchi
authors.forename: Shinji
authors.initials: S
authors.lastname: Tanaka
authors.forename: Hideki
authors.initials: H
authors.lastname: Ishikawa
authors.forename: Hisao
authors.initials: H
authors.lastname: Tajiri
mesh_terms: D000328:Adult; D000368:Aged; D053704:Capsule Endoscopy / Q000009:adverse effects / Q000379:methods*; D003113:Colonoscopy / Q000379:methods*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010865:Pilot Projects; D011446:Prospective Studies